Systems and Methods for Internal Drug Loading for Infusion Processes
M. Swinney · Eli Lilly and Company
US20250144292-A1 (2025), WO/2023/158648 (2023), AU2023220968, CN118695884, EP4479106, JP2025505561
Intellectual Property
Inventor on 37 issued US patents, 22 published US applications, and 50 international patents and applications — organized below into invention families spanning drug delivery, biosensors, and medical devices, all in the public domain.
Showing 15 patents
M. Swinney · Eli Lilly and Company
US20250144292-A1 (2025), WO/2023/158648 (2023), AU2023220968, CN118695884, EP4479106, JP2025505561
M. Swinney · Eli Lilly and Company
US20240277907-A1 (2024), WO/2023/004105 (2023), CN117677411, EP4373537
M. Swinney · Eli Lilly and Company
US20250329432-A1 (2025), US12380981-B2 (2025), US11901060-B2 (2024), JP2022172230-B1 (2022), WO/2019/125932 (2019), AU2024202178, AU2022201374, AU2018388898, CA3085930, CN118217478, CN111542884, EP3729446
M. Swinney · Eli Lilly and Company
US11510967-B2 (2022), WO/2019/050749
M. Swinney · Eli Lilly and Company
US20220160954-A1 (2022), WO 214633 (2020), AU2020258868, EP3955989
M. Swinney · Becton, Dickinson and Company
US12156975-B2 (2024), US11690973-B2 (2023), US11458281-B2 (2022), WO/2013/103864 (2013), CA2860511, EP2800590, JP2017209592
M. Swinney · Eli Lilly and Company
US20190091446-A1 (2019), WO/2017/184857 (2017), AU2017253254, CA3018984, CN109069800, EP3445437, JP2019512348
M. Swinney · Eli Lilly and Company
US11045601-B2 (2021), WO/2017/184985 (2017), AU2017252458, CA3018985, CN109069740, EP3445424, ES2959428, JP2019509873
M. Swinney · Becton, Dickinson and Company
USD806241-S1 (2017)
M. Swinney (M. Rixman) · DexCom, Inc.
US20240180462-A1 (2024), US20200359949-A1 (2020), US10022078-B2 (2018), US9986942-B2 (2018), WO/2011/127694 (2011), US7828728-B2 (2010), US20090036763-A1 (2009), WO/2007/136390 (2007), WO/2007/120381 (2007), US 20070045902-A1 (2007), US 20060270922-A1 (2006)
M. Swinney (M. Rixman) · DexCom, Inc.
US12433485-B2 (2025), US10791928-B2 (2020), US10376143-B2 (2019), US9763609-B2 (2017), US8364229-B2 (2013), US20200359949-A1 (2020), US 20200037875-A1 (2020), US 20200037874-A1 (2020), US 20190335997-A1 (2019), US20140128704-A1 (2014)
M. Swinney (M. Rixman) · DexCom, Inc.
US20240000352-A1 (2024), US11730407-B2 (2023), US10143410-B2 (2018), US9693721-B2 (2017), US 9572523-B2 (2017), US9566026-B2 (2017), US9549699-B2 (2017), US9173607-B2 (2015), US9173606-B2 (2015), US8954128-B2 (2015), US8682408-B2 (2014), US8583204-B2 (2013), US20090247856-A1 (2009), US 20090247855-A1 (2009), WO/2009/121026 (2009), CN102047101, EP2257794
M. Swinney (M. Rixman) · DexCom, Inc.
US11020026-B2 (2021), US20210345916-A1 (2021), US10052051-B2 (2018), US9549693-B2 (2017), US8543184-B2 (2013), US8064977-B2 (2011), US7613491-B2 (2009), WO/2007/120129 (2007), EP2007278, US20060258761-A1 (2006)
M. Swinney (M. Rixman) · DexCom, Inc.
US8929968-B2 (2015), US8483793-B2 (2013), US7896809-B2 (2011), US7761130-B2 (2010), US20100185071-A1 (2010), WO/2007/120442 (2007), WO/2006/127694 (2006)
M. Swinney · LiquiGlide, Inc.
US20260130785-A1 (2026), WO/2024/254064 (2024), CA3294853, EP4719294